What podcasts say about Renée Svernovski
Every statement, with the speaker, the exact quote and the moment it was said.
What Renée Svernovski has said on podcasts
40 statements · 19 positive · 17 negative · 3 mixed · 1 neutral
Higher rates and inflation are reducing buyer capacity and causing sellers to withdraw listings.
“buyers just don't have the ability to spend as much sellers often are still anchored to higher prices and so rather than taking things to auction they're just pulling them off the market”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 4:57
Long-term Australian house-price declines are necessary for affordability.
“in the long term, we need it to happen”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 8:26
Anthropic must become profitable or raise substantial additional debt and equity.
“they're losing money it means they're either going to need to find a way to be meaningfully profitable to fund that or they're going to need to tap debt markets and equity markets for a lot more money”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 11:44
Firmus has weaker operating metrics but a higher valuation than three competitors.
“it has less current capacity, less revenue, a smaller compute backlog, less cash on hand, and a higher valuation than its three competitors”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 26:56
IREN appears preferable to Firmus because it has more revenue and compute at half the market cap.
“if I compare Iron and Firmus, it's like trading at half the market cap. It's got a heap more revenue, more compute. It feels like Iron over Firmus.”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 27:50
Investors who believe in AI need not rush to buy Firmus.
“if you're a believer in this thing you don't have to rush out and buy firmas”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 28:45
IPO incentives can inflate valuations, so investors need not rush to buy generational companies.
“there's a lot of incentives to pump the value as high as possible. And then there's always, like you have, if they're a generational company, you have plenty of time to buy them. You don't have to rush this.”
Open the episode · Two IPOs test the AI hype, Aussie property keeps falling & a closer look at FirmusListen at 29:48
Fertility below 1.3 creates a demographic cliff that cannot be reversed.
“They say that 1.3 is like a demographic cliff. If you go below there, you can't recover.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 0:13
Economic uncertainty and high housing costs delay family formation and childbearing.
“economic uncertainty delays family formation, high house prices delay getting into housing and all of that delays actually having kids.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 4:02
Population aging shrinks the tax base while increasing the number needing support.
“as your population pyramid inverts, all of a sudden your tax base gets smaller and the number of people that you need to support with that tax base gets larger.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 6:25
Population aging drives structural deficits, debt expansion, and higher government borrowing yields.
“Deficits become more structural. Government debt expands. Then all of a sudden the bond market needs higher yields to continue funding those deficits.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 6:34
China’s STAR 50 index trades at approximately 150 times earnings.
“The star 50 index trades at 150 times earnings.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 13:12
A humanoid robot surpassed Usain Bolt’s 100-meter sprint record.
“A humanoid robot broke Usain Bolt's 100-meter sprint record.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 18:51
A robot surpassed the human standing high-jump record.
“A robot reached 2.88 meters, surpassing the human record of 2.45 meters.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 19:39
China produced 85% of the world’s humanoid robots in 2025.
“China in 2025 produced 85% of the world's humanoid robots.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 22:32
Humanoid robots will continue gaining capabilities.
“It's only going in one direction.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 22:49
Core investment factors experience periods of meaningful outperformance.
“some of those core factors definitely do have periods of meaningful outperformance.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 28:18
Factor ETFs can underperform for long periods before outperforming.
“investors need to be willing to accept long periods of underperformance and then enjoy their periods of outperformance”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 31:51
Investors should use factor ETFs as portfolio tilts alongside a broad-market core.
“you should think about having a core portfolio that gives you market exposure and then using factor ETFs to tilt them in specific ways that you want.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 32:16
Factor ETFs should adjust portfolios rather than constitute the entire core.
“factor ETFs are tilt. Use them to adjust your portfolio. Don't have them as your whole core portfolio.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 35:16
Investors should not chase recently successful factors.
“don't chase factors.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 36:11
Buying the overall market is the ultimate blend of investment factors.
“the ultimate blend of factors is just buying the overall market.”
Open the episode · Money can’t fix a population crisis, a robot just beat Usain Bolt & an introduction to factor investingListen at 36:52
Moderna has made substantial progress against cancer but has not cured it.
“Moderna certainly didn't cure cancer, but it has taken a big whack at it, I think.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 0:07
Moderna shares rose 177% in one day after the announcement.
“Shares jumped 177% in a day.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 2:52
Moderna remains 60% below its all-time high despite its recent gain.
“Even after its 177% gain, it's still down 60% from its all-time highs.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 3:17
Moderna short interest was approximately 13.5% of free float.
“short interest in Moderna's shares was about 13.5% of shares on issue, of free float.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 4:43
AI-enabled drug discovery and genomic analysis will produce major breakthroughs.
“There is some incredible breakthroughs coming.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 8:03
Late-stage clinical trials remain costly, burdensome, and regulatory-intensive.
“late stage clinical trials is still an incredibly burdensome and costly and regulatory, regulatorily intensive choke point.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 8:53
Large pharmaceutical companies will ultimately prevail at regulatory bottlenecks.
“that's where the big pharmaceutical companies are still going to ultimately win. Come out on top.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 9:31
The community portfolio is up 8.2% year to date.
“Our portfolio is up 8.2% year to date.”
Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?Listen at 10:45
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.